Biosimilar Insulin In The Management Of Diabetes In Patients

Speciality: Endocrinology


Speaker:

Dr. Shehla Shaikh | DM (ENDOCRINOLOGY), MD (GENERAL MEDICINE)

Dr. Sujoy Ghosh | MBBS, MD, DM(ENDOCRINOLOGY), MRCP(UK), FRCP(LONDON, GLASGOW, EDINBURGH)

Description:

A warm welcome to all the medical practitioners in this interesting session of biosimilar insulin.

Insulin is a hormone secreted from pancreas that helps blood sugar to enter the body's cells so it can be used for energy. Insulin also signals the liver to store blood sugar for later use. It is one of the important components that helps in controlling diabetes in patients.

The speakers Dr. Shehla Shaikh, Dr. Sujoy Ghosh, and panel has provided an elaborative knowledge on biosimilar insulin in the management of diabetes in patients. 

Biosimilar insulins are manufactured in living organisms (e.g., yeast and bacteria) to produce large quantities of the product, which limits the ability to manufacture exact replicas of original biological medications. The manufacture and use of biosimilar insulin will be much cost effective and can be used in lower or middle income countries. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 


See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Remote monitoring can improve recovery from cancer surgery

2.

Intractable cancers may respond better to treatment when using new radiation and high-performance computing.

3.

A Win for AI in Cancer; 2025's Transformative Drugs; FDA Clarifies 'Underway' Trials

4.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

5.

high response rate when using a bispecific antibody to treat R/R multiple myeloma.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot